Main competitors
Consensus (Composite) Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Ecart obj. / dr Nbr of analysts
US$20.63 +350.33% 8
€667.33 +43.79% 16
CN¥83.08 +18.02% 18
US$116.8 +22.55% 21
US$113.22 +17.76% 18
US$25.65 +52.36% 9
HK$27.24 +16.12% 26
DKK 1,936.2 +42% 16
HK$96.14 -4.06% 20
US$45 +3.42% 19
HK$321.97 -6.13% 16
US$119.09 +37.11% 11
US$75.07 +100.24% 20
US$423.14 +47.17% 14
NT$700.5 +33.68% 4
CN¥99.04 +7.28% 2
₹379.2 +2.67% 20
US$117.3 +48.91% 10
HK$36.44 -41.28% 15
Average 284.37 +41.68% 15
Weighted average by Cap. 310.73 +26.56% 17
Bio Therapeutic Drugs